tiprankstipranks
P3 Health Partners (PIII)
NASDAQ:PIII
US Market
Want to see PIII full AI Analyst Report?

P3 Health Partners (PIII) Blogger Opinions & Sentiment

173 Followers

Blogger Sentiment

Bearish: 100.00%
Sector Average
Bearish
PIII Blogger sentiment is based on 1 Blogger Opinions. The Blogger sentiment is more Bearish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
100% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Is P3 Health Partners Inc (PIII) Overvalued After Q2 Earnings? Revenue Reaches $386 Million with Adjusted EBITDA of $54.4 Million -- GF Score: 44/100
GuruFocus
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any
Blogger Name
Blogger Rank
Blog
Date
Blogger Sentiment​
Article
Follow

FAQ

What do Seeking Alpha bloggers think of PIII?
Currently there's no blogger sentiment for PIII.
What do Motley Fool contributors think of PIII?
Currently there's no blogger sentiment for PIII.
What Is PIII’s Blogger Sentiment?
PIII’s Blogger Sentiment is Bearish.
    What was the most recent blogger prediction for PIII?
    The most recent blogger prediction for PIII was made by GuruFocus News, who was Bearish on the stock.
      How can I follow the stock ratings of top Top Financial Bloggers?
      Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Stocks with the Highest Top Blogger Ratings in the Healthcare sector
        CADLCandel Therapeutics
        MLTXMoonLake Immunotherapeutics
        ZVRAZevra Therapeutics
        SMMTSummit Therapeutics
        TGTXTG Therapeutics